ClinicalTrials.gg
RecruitingNCT07883057Updated Oct 20, 2026

Comparison of Operative Hysteroscopy and Vacuum Aspiration for Terminating First-trimester Pregnancy With Intrauterine Adhesions

An observational study in Pregnancy Complicated With Intrauterine Adhesion, sponsored by Women's Hospital School Of Medicine Zhejiang University. Recruiting at 1 site in China. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Women's Hospital School Of Medicine Zhejiang University · Observational

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
360
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

In cases of early pregnancy complicated with intrauterine adhesions (IUAs), termination of pregnancy is prone to incomplete abortion with retained gestational products, failed abortion or uterine perforation due to altered uterine cavity structure and gestational sac obscured by adhesive bands. Reoperation may even be required, which increases the risk of surgical trauma, as well as the psychological and financial burdens on patients. Meanwhile, some patients with IUAs still have fertility demands in the future, so the adhesions also need to be addressed.

Hysteroscopy allows direct visualization to remove intrauterine gestational contents, lowering the risks of tissue retention and reoperation. It also enables concurrent treatment of existing IUAs. Combined with postoperative interventions to prevent adhesion recurrence, this approach can restore the uterine cavity structure and endometrium, improve subsequent fertility, and reduce patients' psychological stress as well as the time and economic costs incurred by repeated hospital admissions and surgeries for IUAs.

This clinical controlled study aims to explore the clinical outcomes and advantages of hysteroscopy applied for termination of early pregnancy combined with simultaneous management of IUAs, so as to provide reliable evidence for the clinical application of combined hysteroscopic abortion and adhesiolysis in such patients. In addition, immunohistochemical detection of decidual tissues will be performed to analyze the influences of immune cell subsets, inflammatory markers, vascular remodeling-related markers and other indicators on the disease, offering references for its clinical management and treatment.

This is a prospective controlled study. Eligible patients diagnosed with early pregnancy complicated with IUAs who underwent pregnancy termination in the Family Planning Ward of our hospital will be enrolled from the date of ethical approval in accordance with the inclusion and exclusion criteria. Patients are divided into two groups: the experimental group receives hysteroscopic abortion combined with simultaneous adhesiolysis, and the control group undergoes ultrasound-guided artificial abortion.

After being fully informed of the pros and cons of both surgical procedures, patients will select their preferred operation voluntarily. General patient information will be recorded, including age, obstetric history, fetal viability of the current pregnancy, intraoperative blood loss, placement of anti-adhesive materials in the uterine cavity and postoperative estrogen administration. Postoperative follow-up will be conducted for 2 years after the enrollment of the last subject, with observed indicators including the rate of residual gestational tissue, recurrence rate of IUAs and subsequent pregnancy outcomes.

Appropriate statistical descriptive indicators and analytical methods will be selected based on the research objectives, data types and distribution characteristics. Statistical differences and clinical implications between the two surgical protocols will be compared and analyzed

02

Conditions studied

  • Pregnancy Complicated With Intrauterine Adhesion
03

In context

Lead sponsor

Women's Hospital School Of Medicine Zhejiang University is the lead sponsor of 79 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Female patients aged 18-40 years diagnosed with intrauterine adhesions and early intrauterine pregnancy who voluntarily receive abortion surgery in our hospital. Patients with molar pregnancy, incomplete follow-up data and surgery performed outside our hospital are excluded.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. patients with transvaginal ultrasound findings suggestive of IUA;
  2. patients who underwent follow-up postoperative ultrasound examinations for 3 or more months at the study hospital;
  3. patients with a desire to bear children;
  4. patients with no significant organic diseases.

Exclusion criteria

Exclusion Criteria:

  1. patients with ectopic pregnancies, e.g., a cesarean scar pregnancy, angular pregnancies, or a cervical pregnancy;
  2. patients who underwent other intrauterine surgical procedures, such as endometrial polypectomy, submucosal myomectomy, or uterine septum resection, during hysteroscopy;
  3. patients who underwent medical termination of pregnancy with oral mifepristone plus misoprostol without surgery;
  4. patients with abnormal postoperative pathological results, e.g., molar pregnancy;
  5. patients without follow-up data or ultrasound results or with incomplete data for 3 months after surgery;
  6. patients whose initial surgery was not performed at the study hospital.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
360 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • Vacuum Aspiration Group

    Procedure: Vacuum Aspiration Group

  • Hysteroscopy Group

    Procedure: Hysteroscopy adhesiolysis combined with vacuum aspiration

Interventions

  • ProcedureVacuum Aspiration Group

    Vacuum Aspiration Group: Negative pressure aspiration was performed using a rigid vacuum cannula

  • ProcedureHysteroscopy adhesiolysis combined with vacuum aspiration

    Hysteroscopic intrauterine adhesiolysis is performed to separate adhesions, after vacuum aspiration for early pregnancy termination.

06

What researchers measure

Primary outcomes

  1. Rate of subsequent pregnancy after surgery

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Aug 2030, 44 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 29, 2026
First posted
Oct 20, 2026
StartEst.
Dec 2026
Primary completionEst.
Aug 2030
CompletionEst.
Aug 2030
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883057
Lead sponsor
Women's Hospital School Of Medicine Zhejiang University
Responsible party
Sponsor
First posted
Oct 20, 2026
Start date
Dec 2026 (estimated)
Primary completion
Aug 2030 (estimated)
Completion
Aug 2030 (estimated)
Last update
Oct 20, 2026

Study contacts

Jiang Xiuxiu
Contact
5515036@zju.edu.cn
+86 15167147558

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion